http://www.advfn.com/nasdaq/rss.asp?symbol=IMMU Immunomedics Company Newsfeed en Tue, 02 Apr 2013 09:18:31 EDT Tue, 02 Apr 2013 09:18:31 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMMU&article=56990646&headline=u-s-hot-stock-futures-hot-stocks-to-watch http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMMU&article=56990646&headline=u-s-hot-stock-futures-hot-stocks-to-watch <div class='newsbody'><p> Among the companies with shares expected to actively trade in Tuesday's session are BGC Partners Inc. (BGCP), Obagi Medical Products Inc. (OMPI) and Humana Inc. (HUM). </p> <p> NASDAQ OMX Group Inc. (NDAQ) agreed to acquire the eSpeed platform from BGC in a cash-and-stock deal... Tue, 02 Apr 2013 09:18:31 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMMU&article=56980725&headline=immunomedics-to-receive-16-7-million-payment-to-resolve-finra http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMMU&article=56980725&headline=immunomedics-to-receive-16-7-million-payment-to-resolve-finra <div class='newsbody'><pre> By Kristin Jones </pre> <p> Immunomedics Inc. (IMMU) expects to receive a total payment of $16.7 million after reaching a settlement with its former broker, resolving allegations the drug company had brought to the Financial Industry Regulatory Authority related its investments... Mon, 01 Apr 2013 18:26:26 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMMU&article=45198217&headline=human-genome-glaxo-to-face-fda-panel-for-lupus-drug http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMMU&article=45198217&headline=human-genome-glaxo-to-face-fda-panel-for-lupus-drug <div class='newsbody'><pre> By Thomas Gryta Of DOW JONES NEWSWIRES </pre> <p> NEW YORK -(Dow Jones)- Human Genome Sciences Inc. (HGSI) and GlaxoSmithKline Plc (GSK, GSK.LN) are seeking to take a significant step next week in getting regulatory approval for the first new treatment to fight the autoimmune... Thu, 11 Nov 2010 16:36:43 EST